303 related articles for article (PubMed ID: 31356619)
1. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
[TBL] [Abstract][Full Text] [Related]
2. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
Zhang X; Kim CY; Worthen T; Witola WH
Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
[TBL] [Abstract][Full Text] [Related]
3. Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against
Khan SM; Bajwa MR; Lahar RY; Witola WH
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056923. PubMed ID: 37655889
[No Abstract] [Full Text] [Related]
4. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
[TBL] [Abstract][Full Text] [Related]
7. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
[No Abstract] [Full Text] [Related]
9. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
[TBL] [Abstract][Full Text] [Related]
10.
Khan SM; Zhang X; Witola WH
Front Microbiol; 2021; 12():800293. PubMed ID: 35046922
[No Abstract] [Full Text] [Related]
11. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.
Maruyama H; Tanaka M; Hashimoto M; Inoue M; Sasahara T
Life Sci; 2007 Jan; 80(8):775-81. PubMed ID: 17157323
[TBL] [Abstract][Full Text] [Related]
12. In-silico screening of small molecule inhibitors against Lactate Dehydrogenase (LDH) of Cryptosporidium parvum.
Dhal AK; Pani A; Mahapatra RK; Yun SI
Comput Biol Chem; 2018 Dec; 77():44-51. PubMed ID: 30240985
[TBL] [Abstract][Full Text] [Related]
13. Targeted gene knockdown validates the essential role of lactate dehydrogenase in Cryptosporidium parvum.
Witola WH; Zhang X; Kim CY
Int J Parasitol; 2017 Nov; 47(13):867-874. PubMed ID: 28606696
[TBL] [Abstract][Full Text] [Related]
14. Prodrug activation by Cryptosporidium thymidine kinase.
Sun XE; Sharling L; Muthalagi M; Mudeppa DG; Pankiewicz KW; Felczak K; Rathod PK; Mead J; Striepen B; Hedstrom L
J Biol Chem; 2010 May; 285(21):15916-22. PubMed ID: 20231284
[TBL] [Abstract][Full Text] [Related]
15. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
Funkhouser-Jones LJ; Ravindran S; Sibley LD
mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
[No Abstract] [Full Text] [Related]
16. A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.
Sharling L; Liu X; Gollapalli DR; Maurya SK; Hedstrom L; Striepen B
PLoS Negl Trop Dis; 2010 Aug; 4(8):e794. PubMed ID: 20706578
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.
Ahmed SA; El-Mahallawy HS; Karanis P
Parasitol Res; 2019 Jul; 118(7):2053-2063. PubMed ID: 31187224
[TBL] [Abstract][Full Text] [Related]
18. Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Maurya SK; Gollapalli DR; Kirubakaran S; Zhang M; Johnson CR; Benjamin NN; Hedstrom L; Cuny GD
J Med Chem; 2009 Aug; 52(15):4623-30. PubMed ID: 19624136
[TBL] [Abstract][Full Text] [Related]
19. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro.
Wanyiri JW; Techasintana P; O'Connor RM; Blackman MJ; Kim K; Ward HD
Eukaryot Cell; 2009 Apr; 8(4):470-7. PubMed ID: 19168760
[TBL] [Abstract][Full Text] [Related]
20. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
Asadpour M; Namazi F; Razavi SM; Nazifi S
Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]